Burdett E, Mills G B, Klip A
Department of Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada.
Am J Physiol. 1990 Jan;258(1 Pt 1):C99-108. doi: 10.1152/ajpcell.1990.258.1.C99.
Guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S), a specific activator of G proteins, did not change the Kd nor total binding of [125I]insulin in plasma membranes from rat liver. Insulin did not alter GTP gamma 35S binding nor polypeptide ADP ribosylation in crude and plasma membranes catalyzed either intrinsically or by cholera toxin. In L6 muscle cells, insulin caused tyrosine phosphorylation of a polypeptide of Mr 160,000. Cell electroporation enabled testing of G protein action in this cellular system. Phosphorylation of the Mr 160,000 polypeptide in these permeabilized cells was insulin and ATP dependent but other small molecules or ionic gradients were not essential. The reaction could not be mimicked by the G protein agonist GTP gamma S nor inhibited by the G protein antagonist guanosine 5'-O-(2-thiodiphosphate) (GDP beta S). However, GTP gamma S effectively decreased insulin-mediated phosphorylation of this polypeptide. This suggests that the tyrosine kinase activity of the insulin receptor can be modulated by G protein agonists. It is concluded that cross talk between the insulin receptor and G proteins could not be demonstrated in isolated membranes by strategies that detect interactions between beta-adrenergic receptors and G proteins. In contrast, in permeabilized cells, G protein-mediated regulation of the insulin receptor kinase activity could be detected.
鸟苷 5'-O-(3-硫代三磷酸)(GTPγS)是一种 G 蛋白的特异性激活剂,它不会改变大鼠肝脏质膜中[125I]胰岛素的解离常数(Kd)或总结合量。胰岛素不会改变粗膜和质膜中 GTPγ35S 的结合,也不会改变由霍乱毒素内在催化或其催化的多肽 ADP 核糖基化。在 L6 肌肉细胞中,胰岛素导致一种分子量为 160,000 的多肽发生酪氨酸磷酸化。细胞电穿孔能够在这个细胞系统中测试 G 蛋白的作用。在这些通透细胞中,分子量为 160,000 的多肽的磷酸化依赖于胰岛素和 ATP,但其他小分子或离子梯度并非必需。G 蛋白激动剂 GTPγS 无法模拟该反应,G 蛋白拮抗剂鸟苷 5'-O-(2-硫代二磷酸)(GDPβS)也无法抑制该反应。然而,GTPγS 有效地降低了胰岛素介导的该多肽的磷酸化。这表明胰岛素受体的酪氨酸激酶活性可被 G 蛋白激动剂调节。得出的结论是,通过检测β-肾上腺素能受体与 G 蛋白之间相互作用的策略,在分离的膜中无法证明胰岛素受体与 G 蛋白之间存在相互作用。相反,在通透细胞中,可以检测到 G 蛋白介导的胰岛素受体激酶活性调节。